Efficacy and safety of topical JTE-052, a Janus kinase inhibitor, in Japanese adult patients with moderate-to-severe atopic dermatitis: a phase II, multicentre, randomized, vehicle-controlled clinical study
出版年份 2018 全文链接
标题
Efficacy and safety of topical JTE-052, a Janus kinase inhibitor, in Japanese adult patients with moderate-to-severe atopic dermatitis: a phase II, multicentre, randomized, vehicle-controlled clinical study
作者
关键词
-
出版物
BRITISH JOURNAL OF DERMATOLOGY
Volume 178, Issue 2, Pages 424-432
出版商
Wiley
发表日期
2017-09-28
DOI
10.1111/bjd.16014
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A novel JAK inhibitor JTE-052 reduces skin inflammation and ameliorates chronic dermatitis in rodent models: Comparison with conventional therapeutic agents
- (2017) Atsuo Tanimoto et al. EXPERIMENTAL DERMATOLOGY
- JAK inhibitors in dermatology: The promise of a new drug class
- (2017) William Damsky et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial
- (2016) R. Bissonnette et al. BRITISH JOURNAL OF DERMATOLOGY
- Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016
- (2016) Hidehisa Saeki et al. JOURNAL OF DERMATOLOGY
- 518 The effect of janus kinase inhibitor on pruritus in an atopic dermatitis murine model
- (2016) Y. Yamamoto et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Tofacitinib improves pruritus and health-related quality of life up to 52 weeks: Results from 2 randomized phase III trials in patients with moderate to severe plaque psoriasis
- (2016) Steven R. Feldman et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- JAK3 as an Emerging Target for Topical Treatment of Inflammatory Skin Diseases
- (2016) Ana Karina Alves de Medeiros et al. PLoS One
- The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling
- (2015) Wataru Amano et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Treatment of recalcitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate
- (2015) Lauren L. Levy et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Pharmacological properties of JTE-052: a novel potent JAK inhibitor that suppresses various inflammatory responses in vitro and in vivo
- (2014) Atsuo Tanimoto et al. INFLAMMATION RESEARCH
- New concept of the pathogenesis of atopic dermatitis: Interplay among the barrier, allergy, and pruritus as a trinity
- (2013) Kenji Kabashima JOURNAL OF DERMATOLOGICAL SCIENCE
- JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease
- (2012) John J. O'Shea et al. IMMUNITY
- Functions of thymic stromal lymphopoietin in immunity and disease
- (2012) Yanlu Zhang et al. IMMUNOLOGIC RESEARCH
- Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases
- (2012) Akiharu Kubo et al. JOURNAL OF CLINICAL INVESTIGATION
- Filaggrin Mutations Associated with Skin and Allergic Diseases
- (2011) Alan D. Irvine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Management of Itch in Atopic Dermatitis
- (2011) Judith Hong et al. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY
- Cytokine modulation of atopic dermatitis filaggrin skin expression
- (2009) Michael D. Howell et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Atopic Dermatitis
- (2008) Thomas Bieber NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now